QUAL vs XBI
iShares MSCI USA Quality Factor ETF vs SPDR S&P Biotech ETF
- • QUAL has the lower expense ratio at 0.15% vs 0.35% for XBI.
- • QUAL pays a higher dividend yield (0.86%).
Side-by-side metrics
| Metric | QUAL | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.86% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $45.92B | $10.73B |
YTD return | 9.64% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.90 | 1.10 |
P/E ratio | 27.79 | — |
Last price | $218.50 | $164.28 |
Inception | — | — |
Issuer | iShares | State Street |
QUAL top holdings
| AAPL | Apple Inc | 6.20% |
| NVDA | NVIDIA Corp | 5.81% |
| MSFT | Microsoft Corp | 5.73% |
| LRCX | Lam Research Corp | 5.15% |
| AMAT | Applied Materials Inc | 4.41% |
| KLAC | KLA Corp | 4.07% |
| TJX | TJX Companies Inc | 3.82% |
| LLY | Eli Lilly and Co | 3.81% |
| META | Meta Platforms Inc Class A | 3.72% |
| V | Visa Inc Class A | 2.96% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About QUAL
QUAL (iShares MSCI USA Quality Factor ETF) is US large-caps screened for quality factors. Managed by iShares, the fund carries $45.9B in assets under management, an expense ratio of 0.15%, a dividend yield of 0.86%. Its largest holding is Apple Inc (AAPL), which represents 6.2% of the portfolio. Real Estate is the fund's largest sector exposure at 1.7%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.